Welcome to LookChem.com Sign In|Join Free
  • or
Benzaldehyde, 2,6-dichloro-4-[[[tris(1-methylethyl)silyl]oxy]methyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

616195-95-0

Post Buying Request

616195-95-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

616195-95-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 616195-95-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,6,1,9 and 5 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 616195-95:
(8*6)+(7*1)+(6*6)+(5*1)+(4*9)+(3*5)+(2*9)+(1*5)=170
170 % 10 = 0
So 616195-95-0 is a valid CAS Registry Number.

616195-95-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-dichloro-4-(triisopropylsiloxymethyl)benzaldehyde

1.2 Other means of identification

Product number -
Other names 2,6-dichloro-4-(triisopropylsilyloxymethyl)benzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:616195-95-0 SDS

616195-95-0Relevant academic research and scientific papers

TETRACYCLIC INHIBITORS OF JANUS KINASES

-

Page/Page column 99-100, (2008/06/13)

The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

NOVEL IMIDAZOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS

-

Page/Page column 24, (2008/06/13)

Compounds of the general formula (I) are valuable therapeutics for the treatment of cancer and cancer related diseases.

Simple, short and efficient procedure for the preparation of hydroxyl- and hydroxymethyl-substituted 2,6-dichlorobenzaldehydes

Von Hirschheydt, Thomas,Voss, Edgar

, p. 2062 - 2065 (2007/10/03)

Hydroxyl- and hydroxymethyl-substituted 2,6-dichlorobenzaldehydes 1-4 have been obtained by lithiation of the corresponding TIPS-protected dichlorophenols or dichlorobenzylic alcohols followed by reaction with DMF and subsequent deprotection of the hydroxy group. Yields are high and formation of regioisomers is not observed.

2-(2,6-dichlorophenyl)-diarylimidazoles

-

Page/Page column 7, (2010/11/29)

The invention is directed to compounds of formula (I), which are valuable therapeutics for the treatment of cancer and related diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 616195-95-0